Abattis Bioceuticals (CSE:ATT, Stock Forum) was welcomed by OTC Markets Group (OTCQX :OTCM, Stock Forum) to the Open, Transparent and Connected financial marketplace after the specialty biotechnology firm qualified for trading on the OTCQX®.
According to the news release, the company will commence trading today under the symbol “ATTBF” and US investors can locate current financial disclosures and Real-Time level 2 quotes on www.otcmarkets.com.
OTC Markets Group president and CEO, R. Cromwell Coulson, commented on the company's entry, “”Abattis joins a growing group of Canadian exchange-listed companies that have chosen to trade on the OTCQX market to provide its investors with transparent trading and convenient access to its news and financials. We wish the company continued success.”
Company CEO, Mike Withrow, added, “Abattis Bioceuticals is dedicated to providing a high level of transparency to shareholders.”
Then he concluded, “The upgrade to OTCQX provides investors with increased transparency in financial reporting and disclosure and awareness of the company's activities within the botanical drug and cannabis industry and inspires confidence within the investment community.”
Abattis was in the news recently when the company announced that its information was available on S&P Capital IQ.
Shares bumped 11.76% on the news to $0.76 per share.
Currently there are 57.9m outstanding shares with a market cap of $44.0 million.